STOK Stoke Therapeutics Q4 2025 EPS misses estimates by 333 pushing shares 258 lower in todays session ATAT Atour posts 113 percent Q4 2025 EPS beat as shares dip 161 percent in todays trading ATT Inc T Rising Telecom Impersonation Scams Highlight Operational Risk and Consumer Protection Opportunities